GPC3 and cancer: Patients with cancers positive for both antigen proteins, i.e., HSP70 and GPC3, tended to present a better overall survival (P = 0.08), and tumor markers were reduced more often in patients with peptide-specific CTL induction for at least one of the two peptides (P = 0.031) (Table S4).